{"id":"https://openalex.org/W7127047979","doi":"https://doi.org/10.1097/rhu.0000000000002322","title":"HLA-Cw6 in Psoriatic Arthritis: Clinical Phenotype and Therapeutic Impact","display_name":"HLA-Cw6 in Psoriatic Arthritis: Clinical Phenotype and Therapeutic Impact","alternate_titles":[],"publication_year":2026,"publication_date":"2026-02-02","ids":{"openalex":"https://openalex.org/W7127047979","doi":"https://doi.org/10.1097/rhu.0000000000002322","pmid":"https://pubmed.ncbi.nlm.nih.gov/41622883"},"language":"en","primary_location":{"id":"doi:10.1097/rhu.0000000000002322","doi":"https://doi.org/10.1097/rhu.0000000000002322","is_oa":false,"landing_page_url":"https://doi.org/10.1097/rhu.0000000000002322","pdf_url":null,"source":{"id":"https://openalex.org/S129376536","display_name":"JCR Journal of Clinical Rheumatology","issn_l":"1076-1608","issn":["1076-1608","1536-7355"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCR: Journal of Clinical Rheumatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7127047979"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052346464","display_name":"Cristina Clara Mac\u00eda Villa","orcid":"https://orcid.org/0000-0002-6822-6730","observed_orcids":["https://orcid.org/0000-0002-6822-6730"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Cristina Macia-Villa","raw_affiliation_strings":["Rheumatology"],"raw_orcid":"https://orcid.org/0000-0002-6822-6730","affiliations":[{"raw_affiliation_string":"Rheumatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049239248","display_name":"Jos\u00e9 Ignacio Fern\u00e1ndez-Velasco","orcid":"https://orcid.org/0000-0001-9148-671X","observed_orcids":["https://orcid.org/0000-0001-9148-671X"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Ignacio Fern\u00e1ndez-Velasco","raw_affiliation_strings":["Immunology, University Hospital Ram\u00f3n y Cajal, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, University Hospital Ram\u00f3n y Cajal, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099983919","display_name":"Mauro Ferre-Sanfrancisco","orcid":"https://orcid.org/0009-0001-4941-594X","observed_orcids":["https://orcid.org/0009-0001-4941-594X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mauro Ferre-Sanfrancisco","raw_affiliation_strings":["Rheumatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124707875","display_name":"Daniel Albert Mendoza-Bravo","orcid":"https://orcid.org/0009-0004-5147-385X","observed_orcids":["https://orcid.org/0009-0004-5147-385X"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Albert Mendoza-Bravo","raw_affiliation_strings":["Immunology, University Hospital Ram\u00f3n y Cajal, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, University Hospital Ram\u00f3n y Cajal, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124738634","display_name":"Ana Maria Ruiz-Bejerano","orcid":"https://orcid.org/0009-0006-4645-1781","observed_orcids":["https://orcid.org/0009-0006-4645-1781"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ana Maria Ruiz-Bejerano","raw_affiliation_strings":["Rheumatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124738003","display_name":"Celia Ferrez-Hern\u00e1ndez","orcid":"https://orcid.org/0009-0000-9574-8449","observed_orcids":["https://orcid.org/0009-0000-9574-8449"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Celia Ferrez-Hern\u00e1ndez","raw_affiliation_strings":["Immunology, University Hospital Ram\u00f3n y Cajal, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, University Hospital Ram\u00f3n y Cajal, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084130472","display_name":"J.L. Morell Hita","orcid":"https://orcid.org/0000-0003-1776-9142","observed_orcids":["https://orcid.org/0000-0003-1776-9142"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jose Luis Morell-Hita","raw_affiliation_strings":["Rheumatology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052346464","https://openalex.org/A5084130472","https://openalex.org/A5099983919","https://openalex.org/A5124738634"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"3","first_page":"79","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13328","display_name":"Osteomyelitis and Bone Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hla-cw6","display_name":"HLA-Cw6","score":1.0},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.699999988079071},{"id":"https://openalex.org/keywords/dactylitis","display_name":"dactylitis","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/il-12-23-inhibitors","display_name":"IL-12/23 inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.503000020980835},{"id":"https://openalex.org/keywords/clinical-phenotype","display_name":"clinical phenotype","score":0.6370000243186951},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.6890000104904175},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.48500001430511475},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.4749999940395355},{"id":"https://openalex.org/keywords/eular-criteria","display_name":"EULAR criteria","score":0.42800000309944153},{"id":"https://openalex.org/keywords/caspar-criteria","display_name":"CASPAR criteria","score":0.7020000219345093},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.7009999752044678},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9733999967575073},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6606000065803528},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.6263999938964844},{"id":"https://openalex.org/C3020646490","wikidata":"https://www.wikidata.org/wiki/Q25203551","display_name":"Clinical phenotype","level":4,"score":0.4332999885082245},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.4090999960899353},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3903000056743622},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.3840999901294708},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34709998965263367},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3425999879837036},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.31310001015663147},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28859999775886536},{"id":"https://openalex.org/C124535831","wikidata":"https://www.wikidata.org/wiki/Q4915074","display_name":"Biomarker discovery","level":4,"score":0.2842999994754791},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.2831000089645386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27300000190734863}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015236","descriptor_name":"HLA-C Antigens","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020022","descriptor_name":"Genetic Predisposition to Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/rhu.0000000000002322","doi":"https://doi.org/10.1097/rhu.0000000000002322","is_oa":false,"landing_page_url":"https://doi.org/10.1097/rhu.0000000000002322","pdf_url":null,"source":{"id":"https://openalex.org/S129376536","display_name":"JCR Journal of Clinical Rheumatology","issn_l":"1076-1608","issn":["1076-1608","1536-7355"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCR: Journal of Clinical Rheumatology","raw_type":"journal-article"},{"id":"pmid:41622883","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41622883","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W152654370","https://openalex.org/W1650718183","https://openalex.org/W1964882566","https://openalex.org/W1966731757","https://openalex.org/W2072868900","https://openalex.org/W2077822409","https://openalex.org/W2107242220","https://openalex.org/W2114754630","https://openalex.org/W2137299871","https://openalex.org/W2145159176","https://openalex.org/W2159575132","https://openalex.org/W2207504009","https://openalex.org/W2238184577","https://openalex.org/W2465313621","https://openalex.org/W2499771932","https://openalex.org/W2588611128","https://openalex.org/W2766276187","https://openalex.org/W2789492367","https://openalex.org/W2789704110","https://openalex.org/W2793267565","https://openalex.org/W2801522626","https://openalex.org/W2903830162","https://openalex.org/W2935730002","https://openalex.org/W2936158543","https://openalex.org/W2943923722","https://openalex.org/W2971174910","https://openalex.org/W3088337877","https://openalex.org/W3202120960","https://openalex.org/W4210583098","https://openalex.org/W4288434516","https://openalex.org/W4309245005","https://openalex.org/W4311326697","https://openalex.org/W4316657825","https://openalex.org/W4372333119","https://openalex.org/W4391450511","https://openalex.org/W4402815472","https://openalex.org/W4406207010","https://openalex.org/W4408588441","https://openalex.org/W4415675605"],"related_works":["https://openalex.org/W2325004844","https://openalex.org/W2330588080","https://openalex.org/W1650718183","https://openalex.org/W2137299871","https://openalex.org/W2058528661","https://openalex.org/W2909079983","https://openalex.org/W2766276187","https://openalex.org/W2052897860","https://openalex.org/W3093761267","https://openalex.org/W1986796394"],"abstract_inverted_index":{"BACKGROUND:":[0],"Psoriatic":[1],"arthritis":[2],"(PsA)":[3],"shares":[4],"genetic":[5],"features":[6,233],"with":[7,10,51,187,230],"psoriasis":[8],"(PsO),":[9],"HLA-Cw6":[11,31,61,79,88,183,225,244],"being":[12],"the":[13,28,55,94,174,241],"main":[14],"risk":[15],"allele":[16],"that":[17],"may":[18],"shape":[19],"its":[20],"clinical":[21,34,232],"phenotype.":[22],"This":[23],"study":[24,47],"aimed":[25],"to":[26,78],"evaluate":[27],"association":[29],"between":[30],"status":[32],"and":[33,37,58,66,84,107,118,154,202,212,234,251],"features,":[35],"comorbidities,":[36],"treatment":[38],"outcomes":[39],"in":[40,91,133,170],"PsA.":[41],"METHODS:":[42],"We":[43],"conducted":[44],"a":[45,227,246],"retrospective":[46],"of":[48,93,196,205,243],"426":[49],"patients":[50,135,142],"PsA":[52,207,214,228,249],"who":[53],"fulfilled":[54],"CASPAR":[56],"criteria":[57],"had":[59,155],"documented":[60],"status.":[62],"Demographic,":[63],"clinical,":[64],"laboratory,":[65],"treatment-related":[67],"variables":[68],"were":[69,75,98],"extracted":[70],"from":[71],"medical":[72],"records.":[73],"Patients":[74],"compared":[76],"according":[77],"positivity":[80],"using":[81],"descriptive,":[82],"bivariate,":[83],"multivariate":[85,181],"analyses.":[86],"RESULTS:":[87],"was":[89,129,176,184],"present":[90],"24.6%":[92],"patients.":[95],"HLA-Cw6-positive":[96,134,141],"individuals":[97],"more":[99,144],"frequently":[100],"female":[101,188],"(65.7%":[102],"vs.":[103,113,123,137,148,160],"46.1%,":[104],"P":[105,116,126,139,152,163,192,200,210,217],"=0.001)":[106,211,218],"showed":[108,167],"earlier":[109],"PsO":[110],"onset":[111],"(28.0":[112],"35.3":[114],"y,":[115,125],"=0.009)":[117],"longer":[119,168],"PsO-arthritis":[120],"latency":[121],"(17":[122,159],"9":[124],"=0.024).":[127],"Dactylitis":[128],"significantly":[130],"less":[131],"common":[132],"(25.7%":[136],"38.0%,":[138],"=0.022).":[140],"received":[143],"targeted":[145],"therapies":[146],"(1.8":[147],"1.5":[149],"drug":[150],"classes,":[151],"=0.014)":[153],"shorter":[156],"TNFi":[157],"persistence":[158,169],"36":[161],"mo,":[162],"=0.044).":[164],"IL-12/23":[165],"inhibitors":[166],"this":[171],"group,":[172],"although":[173],"difference":[175],"not":[177],"statistically":[178],"significant.":[179],"In":[180],"models,":[182],"independently":[185],"associated":[186],"sex":[189],"(OR:":[190,198,208,215],"4.11,":[191],"=0.003),":[193],"lower":[194],"frequency":[195],"dactylitis":[197],"0.33,":[199],"=0.020),":[201],"greater":[203],"odds":[204],"difficult-to-manage":[206],"12.53,":[209],"treatment-refractory":[213],"15.39,":[216],"based":[219],"on":[220],"recent":[221],"EULAR":[222],"definitions.":[223],"CONCLUSIONS:":[224],"identifies":[226],"subset":[229],"distinctive":[231],"increased":[235],"therapeutic":[236],"complexity.":[237],"These":[238],"findings":[239],"support":[240],"potential":[242],"as":[245],"biomarker":[247],"for":[248],"characterization":[250],"individualized":[252],"therapy.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7127047979","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2026-02-03T00:00:00"}
